Endoscopic bypass using endobarrier devices: Efficacy in treating obesity and metabolic syndrome

Journal of Clinical Gastroenterology

Volumn 49, Issue 10, 2015, Pages 799-803

  Jain, Deepanshu ^a   Singhal, Shashideep ^b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Diabetes mellitus type 2; Duodenojejunal bypass sleeve; Endobarrier device; Obesity

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

BARIATRIC SURGERY; BYPASS SURGERY; CONTROLLED CLINICAL TRIAL (TOPIC); DIGESTIVE SURGICAL EQUIPMENT; ENDOBARRIER DEVICE; ENDOSCOPIC SURGERY; EXPLANT; GASTRIC SLEEVE; GENERAL ANESTHESIA; HUMAN; IMPLANTATION; INTESTINE BYPASS; LIPID ANALYSIS; MEDICAL DEVICE COMPLICATION; METABOLIC SYNDROME X; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPERATION DURATION; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROUX Y ANASTOMOSIS; STOMACH EMPTYING; SYSTEMATIC REVIEW; TIME; ADVERSE EFFECTS; DEVICES; DUODENUM; GASTROINTESTINAL ENDOSCOPY; JEJUNUM; OBESITY, MORBID; PREOPERATIVE CARE; PROCEDURES; PROSPECTIVE STUDY; WEIGHT REDUCTION;

BARIATRIC SURGERY; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; HUMANS; JEJUNUM; OBESITY, MORBID; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 84944077978     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000396     Document Type: Review

References (18)

1. World Health Organization. Obesity and overweight, fact sheet N1311. 2015. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed March, 2015.
2. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342-362.
3. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and metaanalysis, 2003-2012. JAMA Surg. 2014;149:275-287.
4. Alger-Mayer S, Polimeni JM, Malone M. Preoperative weight loss as a predictor of long-term success following Roux-en-Y gastric bypass. Obes Surg. 2008;18:772-775.
5. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14:275-278.
6. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71:976-982.
7. Rodriques-Grunert L, Galvao Neto MP, Almo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4: 55-59.
8. Sandler BJ, Rumbaut R, Swain CP, et al. Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc. 2011;25:3028-3033.
9. Rodriguez L, Rayes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009;11: 725-732.
10. Escalona A, Yáñez R, Pimental F, et al. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis. 2010;6: 126-131.
11. Escalona A, Pimental F, Sharp A, et al. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg. 2012;255:1080-1085.
12. Muñoz R, Dominguez A, Muñoz F, et al. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients. Surg Endosc. 2014; 28:1056-1062.
13. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251:236-243.
14. Koehestanie P, Betzel B, Dogan K, et al. The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation. Surg Endosc. 2014;28:325-330.
15. De Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013;23:1354-1360.
16. De Moura EG, Orso IR, Martins BC, et al. Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg. 2011;21:941-947.
17. De Moura EG, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther. 2012;14:183-189.
18. Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for preoperative weight loss in bariatric surgery. Surg Endosc. 2009; 23:650-656.